May 2026 • PharmaTimes Magazine • 4-5

Contents

Features

Patients are missing strategy – pharma must seize the day

From listening to action – turning medical insights into patient impact

How AI has strengthened scalability across mid-sized pharma

Who’s really in charge in the NHS? Navigating a disrupted system

Modernisation need in clinical data analysis and regulatory submission

Analysis

GLP-1 drugs – why faster progress won’t fix pharma’s challenges

Why is pharma determined to give AI to patients and HCPs?

Could seven-day timelines could be obsolete by 2028?

Counting the cost of pharma’s change management burden

SmartPeople

14.
Pharma chameleon
Digital maturity gap – how AI is reshaping pharma operations

20.
Real time
Making partnership working business as usual

24.
Kylie’s greatest hits
Building trust with patient organisations – Jess is back

36.
Starting over
There some cool new folk in town and they mean business